Cholamandalam Financial Holdings Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
CHOLAHLDNG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Smallcap 250 and 0.9 pts more than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Cholamandalam Financial Holdings (CFHL) submitted its Q1 FY26 results on August 8, 2025. Consolidated total income rose 22% year-on-year to Rs. 9,383 Cr (vs Rs. 7,677 Cr in Q1 FY25), while consolidated profit after tax grew 9% to Rs. 1,260 Cr (vs Rs. 1,160 Cr). Consolidated EPS stood at Rs. 30.81 versus Rs. 29.20 a year ago. Key financing subsidiary CIFCL (44.34% stake) posted 21% PAT growth to Rs. 1,136 Cr with assets under management up 23% to Rs. 2,07,663 Cr, though disbursements were flat at around Rs. 24,325 Cr. Insurance arm CMSGICL (60% stake) saw GWP rise 6% to Rs. 2,073 Cr but its PAT fell sharply to Rs. 119 Cr from Rs. 211 Cr due to adverse fair value changes on equity investments and higher loss ratios in motor, health and fire segments. Standalone PAT was Rs. 2.11 Cr vs Rs. 1.39 Cr. The statutory auditors R.G.N. Price & Co. issued an unmodified limited review on both sets of results, noting that the prior year comparatives were reviewed by a predecessor auditor.
Broadly positive for shareholders driven by strong 22% top-line growth and 23% AUM expansion at the financing arm, though the sharp decline in insurance subsidiary profit is a yellow flag that may cap near-term upside. The auditor commentary flagging a predecessor auditor suggests a recent auditor change, which is worth noting but the review opinion itself remains clean.